Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

CV-3988

PAF receptor inhibitor
 
BML-L103-0005 5 mg 162.00 USD
Do you need bulk/larger quantities?
 
Competitive PAF receptor antagonist. Inhibits PAF-induced human platelet aggregation (3-30µM) and bronchoconstriction in the guinea-pig. Inhibits PAF-induced hypotension, contraction of isolated rat colon, acute pancreatitis and lethality. Prevents the effects of systemically administered endotoxin. Important standard for comparison with other PAF antagonists.

Product Specification

Formula:C28H53N2O7PS
 
MW:592.8
 
CAS:85703-73-7
 
Purity:≥95% (HPLC)
 
Appearance:White to off-white solid.
 
MeltingPoint:198-203°C
 
Solubility:Soluble in ethanol (15mg/ml).
 
Shipping:Shipped on Dry Ice
 
Long Term Storage:-20°C
 
Use/Stability:Store, as supplied, at -20°C for up to 1 year. Store solutions at -20°C for up to 3 months
 
bml-l103
Please mouse over
bml-l103

Product Literature References

The poly-γ-d-glutamic acid capsule surrogate of the Bacillus anthracis capsule induces nitric oxide production via the platelet activating factor receptor signaling pathway: H.R. Lee, et al.; Mol. Immunol. 68, 244 (2015), Application(s): Cell Culture, Abstract;
Experimental acute pancreatitis induced by platelet activating factor in rabbits: G. Emanuelli, et al.; Am. J. Pathol. 134, 315 (1989), Abstract;
Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis: G. Danko, et al.; Pharmacol. Res. Commun. 20, 785 (1988), Abstract;
Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity: D.A. Robertson, et al.; J. Pharmacol. Exp. Ther. 245, 124 (1988), Abstract;
Study of platelet activating factor and its antagonists on rat colon strip with a new method avoiding tachyphylaxis: A. Tokumura, et al.; Eur. J. Pharmacol. 148, 353 (1988), Abstract;
A lethal role of platelet activating factor in anaphylactic shock in mice: Z. Terashita, et al.; J. Pharmacol. Exp. Ther. 243, 378 (1987), Abstract;
Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet: Z. Terashita, et al.; Biochem. Pharmacol. 34, 1491 (1985), Abstract;
Is platelet activating factor (PAF) a mediator of endotoxin shock: Z. Terashita, et al.; Eur. J. Pharmacol. 109, 257 (1985), Abstract;

Related Literature

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,